Bank of New York Mellon Corp decreased its position in shares of Aetna Inc. (NYSE:AET) by 0.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,352,908 shares of the company’s stock after selling 26,074 shares during the period. Bank of New York Mellon Corp’s holdings in Aetna were worth $660,903,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. State of Alaska Department of Revenue bought a new stake in shares of Aetna during the first quarter worth approximately $1,060,000. Rothschild Investment Corp IL bought a new stake in shares of Aetna during the first quarter worth approximately $225,000. Columbus Circle Investors increased its stake in shares of Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock worth $6,611,000 after buying an additional 40,535 shares during the period. Nisa Investment Advisors LLC increased its stake in shares of Aetna by 2.2% in the first quarter. Nisa Investment Advisors LLC now owns 144,376 shares of the company’s stock worth $18,415,000 after buying an additional 3,060 shares during the period. Finally, Boston Advisors LLC increased its stake in shares of Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock worth $371,000 after buying an additional 500 shares during the period. Institutional investors own 91.69% of the company’s stock.

Aetna Inc. (AET) opened at 155.76 on Wednesday. The firm has a market capitalization of $51.73 billion, a P/E ratio of 34.57 and a beta of 0.54. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69. The firm’s 50-day moving average is $154.49 and its 200 day moving average is $139.88.

Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. During the same period in the previous year, the firm posted $2.21 EPS. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. Equities analysts anticipate that Aetna Inc. will post $9.52 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, July 11th. This represents a $2.00 annualized dividend and a yield of 1.28%. Aetna’s dividend payout ratio (DPR) is presently 43.67%.

TRADEMARK VIOLATION WARNING: “Bank of New York Mellon Corp Sells 26,074 Shares of Aetna Inc. (AET)” was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/bank-of-new-york-mellon-corp-sells-26074-shares-of-aetna-inc-aet/1495319.html.

A number of equities research analysts have recently commented on the company. Royal Bank Of Canada increased their price objective on Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a research report on Friday, August 4th. Jefferies Group LLC restated a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a report on Friday, August 4th. Deutsche Bank AG increased their target price on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a report on Monday, August 7th. Cantor Fitzgerald restated an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Finally, Credit Suisse Group restated an “outperform” rating and issued a $165.00 target price (up previously from $160.00) on shares of Aetna in a report on Thursday, July 13th. Eight analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $157.09.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.14% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.